Stock IMNN IMUNON, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Imunon, Inc.

Equities

IMNN

US15117N6022

Delayed Nasdaq
Other stock markets
 20:50:50 02/05/2024 BST 		5-day change 1st Jan Change
1.31 USD 0.00% Intraday chart for Imunon, Inc. -9.03% +92.65%
04-18 Imunon Receives FDA Approval to Start Phase 1 Trial of COVID-19 Booster Vaccine MT
04-18 Imunon Shares Rise 8% After Clearance to Start Phase 1 Trial for Covid-19 Booster Vaccine DJ

Evolution of the average Target Price on Imunon, Inc.

Price target over the last 5 years

History of analyst recommendation changes

cbccdc07cfe28.LDBY__hGp638sfhV3Id3xz7UeG7AnTXzoRliqYA-fJI.agYVpcl01-XE_K89pt85_k_kLRuo-ma642Eg5bVnCvh2XQyFlw7N7Lrpkw~e5097ae04bf086c78e492e63d7274001

Analyst Recommendations on Imunon, Inc.

HC Wainwright Adjust Price Target on Imunon to $13 From $12, Keeps Buy Rating MT
Alliance Global Starts Imunon at Buy with $15 Price Target MT
HC Wainwright Starts Celsion at Buy With $16 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
1.31 USD
Average target price
12 USD
Spread / Average Target
+816.03%
High Price Target
15 USD
Spread / Highest target
+1,045.04%
Low Price Target
8 USD
Spread / Lowest Target
+510.69%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Imunon, Inc.

HC Wainwright
Alliance Global Partners

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. IMNN Stock
  4. Consensus Imunon, Inc.